BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28402394)

  • 21. MiR224-3p inhibits hypoxia-induced autophagy by targeting autophagy-related genes in human glioblastoma cells.
    Guo X; Xue H; Guo X; Gao X; Xu S; Yan S; Han X; Li T; Shen J; Li G
    Oncotarget; 2015 Dec; 6(39):41620-37. PubMed ID: 26536662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dependence receptor TrkC regulates the number of sensory neurons during DRG development.
    Ménard M; Costechareyre C; Coelho-Aguiar JM; Jarrosson-Wuilleme L; Rama N; Blachier J; Kindbeiter K; Bozon M; Cabrera JR; Dupin E; Le Douarin N; Mehlen P; Tauszig-Delamasure S
    Dev Biol; 2018 Oct; 442(2):249-261. PubMed ID: 30071216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of phosphorylation of TrkB and TrkC and their signal transduction by alpha2-macroglobulin.
    Hu YQ; Koo PH
    J Neurochem; 1998 Jul; 71(1):213-20. PubMed ID: 9648868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are There Thresholds in Glioblastoma Cell Death Responses Triggered by Temozolomide?
    He Y; Kaina B
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnolol and honokiol exert a synergistic anti-tumor effect through autophagy and apoptosis in human glioblastomas.
    Cheng YC; Hueng DY; Huang HY; Chen JY; Chen Y
    Oncotarget; 2016 May; 7(20):29116-30. PubMed ID: 27074557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BK channels blockage inhibits hypoxia-induced migration and chemoresistance to cisplatin in human glioblastoma cells.
    Rosa P; Catacuzzeno L; Sforna L; Mangino G; Carlomagno S; Mincione G; Petrozza V; Ragona G; Franciolini F; Calogero A
    J Cell Physiol; 2018 Sep; 233(9):6866-6877. PubMed ID: 29319175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peiminine Inhibits Glioblastoma in Vitro and in Vivo Through Cell Cycle Arrest and Autophagic Flux Blocking.
    Zhao B; Shen C; Zheng Z; Wang X; Zhao W; Chen X; Peng F; Xue L; Shu M; Hou X; Wang K; Zhong C; Sun J; Wan J; Zhao S
    Cell Physiol Biochem; 2018; 51(4):1566-1583. PubMed ID: 30497066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The HIF‑1α/miR‑224‑3p/ATG5 axis affects cell mobility and chemosensitivity by regulating hypoxia‑induced protective autophagy in glioblastoma and astrocytoma.
    Huang S; Qi P; Zhang T; Li F; He X
    Oncol Rep; 2019 Mar; 41(3):1759-1768. PubMed ID: 30569180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of mitogen-activated protein kinase activation by naturally occurring splice variants of TrkC, the receptor for neurotrophin-3.
    Gunn-Moore FJ; Williams AG; Tavaré JM
    Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):193-8. PubMed ID: 9078261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autophagy inhibition potentiates SAHA‑mediated apoptosis in glioblastoma cells by accumulation of damaged mitochondria.
    Lohitesh K; Saini H; Srivastava A; Mukherjee S; Roy A; Chowdhury R
    Oncol Rep; 2018 Jun; 39(6):2787-2796. PubMed ID: 29658588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel tumor-promoting mechanism of IL6 and the therapeutic efficacy of tocilizumab: Hypoxia-induced IL6 is a potent autophagy initiator in glioblastoma via the p-STAT3-MIR155-3p-CREBRF pathway.
    Xue H; Yuan G; Guo X; Liu Q; Zhang J; Gao X; Guo X; Xu S; Li T; Shao Q; Yan S; Li G
    Autophagy; 2016 Jul; 12(7):1129-52. PubMed ID: 27163161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cycloheximide promotes paraptosis induced by inhibition of cyclophilins in glioblastoma multiforme.
    Wang L; Gundelach JH; Bram RJ
    Cell Death Dis; 2017 May; 8(5):e2807. PubMed ID: 28518150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurotrophin receptors and heparanase: a functional axis in human medulloblastoma invasion.
    Marchetti D; Mrak RE; Paulsen DD; Sinnappah-Kang ND
    J Exp Clin Cancer Res; 2007 Mar; 26(1):5-23. PubMed ID: 17550129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NT-3-mediated TrkC receptor activation promotes proliferation and cell survival of rodent progenitor oligodendrocyte cells in vitro and in vivo.
    Kumar S; Kahn MA; Dinh L; de Vellis J
    J Neurosci Res; 1998 Dec; 54(6):754-65. PubMed ID: 9856859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma.
    Srivastava C; Irshad K; Dikshit B; Chattopadhyay P; Sarkar C; Gupta DK; Sinha S; Chosdol K
    Int J Cancer; 2018 Feb; 142(4):805-812. PubMed ID: 28994107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rational basis for Trk inhibition therapy for prostate cancer.
    Weeraratna AT; Arnold JT; George DJ; DeMarzo A; Isaacs JT
    Prostate; 2000 Oct; 45(2):140-8. PubMed ID: 11027413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SHP-2-dependent mitogen-activated protein kinase activation regulates EGFRvIII but not wild-type epidermal growth factor receptor phosphorylation and glioblastoma cell survival.
    Zhan Y; O'Rourke DM
    Cancer Res; 2004 Nov; 64(22):8292-8. PubMed ID: 15548697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxic and Reoxygenated Microenvironment: Stemness and Differentiation State in Glioblastoma.
    Gaelzer MM; Santos MSD; Coelho BP; de Quadros AH; Simão F; Usach V; Guma FCR; Setton-Avruj P; Lenz G; Salbego CG
    Mol Neurobiol; 2017 Oct; 54(8):6261-6272. PubMed ID: 27714633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human melanoma TrkC: its association with a purine-analog-sensitive kinase activity.
    Marchetti D; Murry B; Galjour J; Wilke-Greiter A
    J Cell Biochem; 2003 Apr; 88(5):865-72. PubMed ID: 12616526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dok5 is involved in the signaling pathway of neurotrophin-3 against TrkC-induced apoptosis.
    Pan Y; Zhang J; Liu W; Shu P; Yin B; Yuan J; Qiang B; Peng X
    Neurosci Lett; 2013 Oct; 553():46-51. PubMed ID: 23954828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.